STOCK MARKET BSE NSE

‘Licence issued to Patanjali for immunity booster, not Covid drug’

In a release, the Ministry said that facts of the claim and details of the stated scientific study are not known to it

Published: 24th June 2020 08:01 PM  |   Last Updated: 25th June 2020 10:35 AM   |  A+A-

Patanjali_ products

Patanjali products. Image used for representation purpose only.

By Express News Service

NEW DELHI/DEHRADUN/JAIPUR: Patanjali Ayurved Ltd faces the risk of losing the licence granted for its new drug Coronil, which the company touted as an effective cure for Covid-19. According to Uttarakhand Ayurveda Department, the Baba Ramdev-promoted company did not mention it was developing a drug for Covid-19 while applying for the licence. The department said it would issue a notice to Patanjali and if the company failed to give a satisfactory reply, the licence would be cancelled.

“We didn’t issue any licence to them for developing a Covid-19 medicine. Patanjali applied for a licence for immunity booster kits only. If we do not get a satisfactory response from them, then their licence will be cancelled soon,” said Y S Rawat, joint director, Uttarakhand’s medicinal licensing authority.

Yoga guru Ramdev during the launch of
‘Coronil’ and ‘Swasari’ in Haridwar | Pti

On Tuesday, Patanjali had launched a Corona kit with the medicines Coronil and Swasari, with Ramdev claiming 100 per cent favourable results during clinical trials. Officials said they are currently probing if there were any violations in the context of the claims. “Based on our probe, we will issue a notice to them under Rule 170 of the Drugs and Cosmetics Act, 1940, seeking details of how they got the permissions to make the kit,” Rawat added.

Hours after the kit was launched, Union AYUSH ministry asked Patanjali not to advertise and sell it till the issue is examined. On Wednesday, AYUSH minister Shripad Naik Shripad Naik said Patanjali coming with the medicine was a “good initiative” , but due process had to be followed. 

The state government had sent all the documents related to the issuance of licence to Patanjali to the AYUSH ministry, as requested.  Ramdev clarified that all documents requested by the ministry had been submitted. “There has seen some miscommunication in the whole process. We have followed all procedures,” he said. 

Trouble is also mounting for Patanjali and privately-owned National Institute of Medical Science in Jaipur which reportedly collaborated with the Patanjali Research Institute for the clinical trials of the medicine. 

The state health department termed the trials as illegal and has served a notice to the hospital. Jaipur’s Chief Medical and Health Officer Dr Narottam Sharma asserted that no official permission was sought or obtained for the so-called trials by Patanjali or NIMS. 

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp